Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer

Updated on: January 03,2024

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer

Updated on:January 03,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on: August 03,2024

Distinct signaling pathway identified as key driver for epithelial cancer development

by Kurt Bodenmüller,University of ZurichSide section of the skin with epidermal stem cells (green) with one particular clone in red. Cell nuclei are stained in blue, the white dashed lines indic

Updated on:August 03,2024

Researchers reveal key to targeting dormant cancer cells

by Garvan Institute of Medical Research3D view of a growing cancer colony and a single dormant cancer cell attached to the inner lining of bone. Credit: Dr Michelle McDonaldAn international team

Updated on: June 11,2024

Researchers reveal key to targeting dormant cancer cells

by Garvan Institute of Medical Research3D view of a growing cancer colony and a single dormant cancer cell attached to the inner lining of bone. Credit: Dr Michelle McDonaldAn international team

Updated on:June 11,2024

Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene

Updated on: June 22,2024

Researchers discover possible new treatment for triple-negative breast cancer

by The Wistar InstituteDr. Zachary Schug, assistant professor at The Wistar Institute. Credit: The Wistar InstituteZachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogene

Updated on:June 22,2024

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w

Updated on: March 05,2024

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w

Updated on:March 05,2024

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on: May 07,2024

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on:May 07,2024

Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorou

Updated on: May 16,2024

Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorou

Updated on:May 16,2024

Liver cancer growth tied to tryptophan intake

byUTSouthwestern Medical CenterSummary of our findings on Trp dependency and vulnerability in MYC-driven tumors. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-478

Updated on: August 27,2024

Liver cancer growth tied to tryptophan intake

byUTSouthwestern Medical CenterSummary of our findings on Trp dependency and vulnerability in MYC-driven tumors. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-478

Updated on:August 27,2024

Scientists find butyrate's possible anticancer potential is cell-type specific

FEBRUARY 27, 2024by Maribel Alonso,Agricultural Research ServiceDistinct effects of butyrate on colon cancer cell lines (A) HCT116, (B) HT-29, (C) Caco-2 cell growth curves for 24, 48, and 72 h,

Updated on: March 15,2024

Scientists find butyrate's possible anticancer potential is cell-type specific

FEBRUARY 27, 2024by Maribel Alonso,Agricultural Research ServiceDistinct effects of butyrate on colon cancer cell lines (A) HCT116, (B) HT-29, (C) Caco-2 cell growth curves for 24, 48, and 72 h,

Updated on:March 15,2024

Cervical cancer burden remains high in many countries; scale-up needed to meet 2030 elimination target

by LancetHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive cance

Updated on: February 18,2024

Cervical cancer burden remains high in many countries; scale-up needed to meet 2030 elimination target

by LancetHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive cance

Updated on:February 18,2024

What causes breast cancer?

by Annika Lund,Karolinska InstitutetMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaThere is a lot

Updated on: March 30,2024

What causes breast cancer?

by Annika Lund,Karolinska InstitutetMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaThere is a lot

Updated on:March 30,2024